However, a new drug may finally change all that. Veradermics, a Connecticut-based biopharmaceutical company, is developing a ...
The first under-the-skin, long-acting risperidone injection offers a new maintenance option for adults with bipolar 1 ...
FDA approves UZEDY ® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback